Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase IIb |
| Species: | Human |
| Stage: | Follow-up (closed to accrual) |
| Study Start Date: | 2016-03-31 |
| Study Made Public: | NA |
Title
A Phase 2b study to evaluate the safety and efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection among men and transgender persons who have sex with men
Description
HVTN 704/HPTN 085 (AMP study) is a Phase IIb clinical trial to evaluate the safety and immunogenicity of VRC-HIVMAB060-00-AB (VRC01 mAb).
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.